SCHEMBL18972703

SCHEMBL18972703

CNCC(=O)N[C@@H]1CC[C@@H](C)C1

nearest known ligand 0.40

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.40
NPC1 O15118 2/20 0.40
EPHX1 P07099 1/20 0.39
GAA P10253 1/20 0.37
LMNA P02545 2/20 0.36
KDM1A O60341 2/20 0.36
MAOB P27338 1/20 0.36
MAPK1 P28482 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD11B1 P28845 1/20 0.34
MTNR1A P48039 1/20 0.34
MTNR1B P49286 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18972807 0.85 MTNR1A (0.46) RAB9ANPC1EPHX1GAAMAPK1
SCHEMBL13349453 0.85 MTNR1A (0.46) RAB9ANPC1EPHX1GAAMAPK1
SCHEMBL23080984 0.85 MTNR1A (0.46) RAB9ANPC1EPHX1GAAMAPK1
SCHEMBL2018813 0.84
SCHEMBL5022149 0.76 ALDH1A1 (0.41) RAB9ANPC1EPHX1GAALMNA
SCHEMBL24322791 0.76 LMNA (0.58) RAB9ANPC1EPHX1LMNASMN1; SMN2
SCHEMBL14191550 0.76 SMYD3 (0.50) LMNASMN1; SMN2
SCHEMBL12820701 0.76 LMNA (0.41) RAB9ANPC1EPHX1LMNAKDM1A
SCHEMBL12424282 0.75 KMT2A (0.60) RAB9ANPC1EPHX1GAALMNA
SCHEMBL15014553 0.75 HSD11B1 (0.42) RAB9ANPC1EPHX1GAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3719022-A1 POLYCYCLIC COMPOUNDS AS INHIBITORS OF BRUTON'S TYROSINE KINASE Janssen Pharmaceutica NV (BE) 2020-10-07 EP disclosed
EP-3386991-B1 POLYCYCLIC COMPOUNDS AS INHIBITORS OF BRUTON'S TYROSINE KINASE JANSSEN PHARMACEUTICA NV (BE) 2020-06-03 EP disclosed
WO-2017100662-A1 POLYCYCLIC COMPOUNDS AS INHIBITORS OF BRUTON'S TYROSINE KINASE JANSSEN PHARMACEUTICA NV (BE) 2017-06-15 WO disclosed